Home Label changed on Biogen's top MS drug to reflect patient death
 

Keywords :   


Label changed on Biogen's top MS drug to reflect patient death

2014-11-25 22:03:21| Biotech - Topix.net

Biogen's Tecfidera was the biggest locally developed drug to be approved in the U.S. in 2013. It's expected to make more than $4 billion in revenue in 2018.

Tags: top death changed drug

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
19.05Atlantic Tropical Weather Outlook
19.05Eastern North Pacific Tropical Weather Outlook
18.05Eastern North Pacific Tropical Weather Outlook
18.05Atlantic Tropical Weather Outlook
18.05M&S website and app hit by technical issue
18.05Eastern North Pacific Tropical Weather Outlook
18.05Atlantic Tropical Weather Outlook
18.05Producers to be paid grid premiums for AngusLink beef scores
More »